Abstract:To examine the mRNA expression of matrix metalloproteinase 9 (MMP-9) and the gelatinase activity of its inhibitor, tissue inhibitor of matrix metalloproteinase 1 (TIMP-1) in the primary epithelial cells of patients with COPD, airway epithelial cells were taken from 15 COPD patients and cultured in vitro. The patients were divided into three groups, COPD group, normal smoking control group and non-smoking control group, with 5 subjects in each group, on basis of the smoking history and lung function. The semi-qualitative RT-PCR was employed to determine the mRNA levels of MMP-9 and TIMP-1 and SDS PAGE was used for the determination of the gelatinase activity of MMP-9 and TIMP-1. Our result showed that the mRNA of MMP-9 and TIMP-1 in epithelial cells of the non-smoking subjects was at a low level. The mRNA of MMP-9 and TIMP-1 in COPD patients and smokers was significantly higher than that in non-smokers (P<0.05). No significant difference was found in the levels of MMP-9 and TIMP-1 in epithelial cells between the COPD patients and smokers. The MMP-9/TIMP-1 ratios in COPD patients and smokers were significantly lower than that of non-smokers (P<0.05). The gelatinase activity in the epithelial cells of both COPD patients and normal smokers was increased (P<0.05), but no difference existed in the gelatinase activity in the epithelial cells between COPD patients and normal smokers. It is concluded that the transcription of MMP-9 and TIMP-1 and the gelatinase activity of MMP-9 and MMP-2 in the epithelial cells in COPD patients were increased, which resulted in an imbalance of MMP-9/TIMP-1, thereby causing pulmonary fibrosis. These factors play important roles in the pathogenesis of COPD.

Expression of Matrix Metalloproteinase-9 Mrna in Osteoporotic Bone Tissues

Expressions of MMP-1,MMP-8 and MMP-13 in gingival tissue of patients with aggressive periodontitis

Bone Morphogenetic Protein 9 Regulates the Cross-Talk Between Breast Cancer Cells and Bone Marrow Mesenchymal Stem Cells

Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis.

Expression of Matrix Metalloproteinase-9 and Their Correlation with Tumor Invasion, Metastasis in Gastric Carcinoma

Bone Morphogenetic Protein 9 Overexpression Reduces Osteosarcoma Cell Migration and Invasion

Biological Roles of Human Bone Morphogenetic Protein 9 in the Bone Microenvironment of Human Breast Cancer MDA-MB-231 Cells.

[Expressions of Matrix Metalloproteinase 9 in Mucosal Natural Killer/t Cell and Mature T Cell Lymphomas and Its Relation to Epstein-Barr Virus Infection].

The Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinases 2,9 in Osteosarcoma

BMP9 Regulates Cross-Talk Between Breast Cancer Cells and Bone Marrow-Derived Mesenchymal Stem Cells.

A STUDY ON THE CORRELATION BETWEEN THE REGULATED EXPRESSION OF MATRIX METALLOPROTEINASE 9(MMP-9) AND THE METASTATIC PHENOTYPE IN HUMAN MELANOMA CELLS

Activity of Matrix Metalloproteinase in Airway Epithelial Cells of COPD Patients.

Inhibition of osteosarcoma metastasis in vivo by targeted downregulation of MMP1 and MMP9

The Role of Matrix Metalloproteinase Expression in Lung Cancer Metastasis

EXPRESSION OF MATRIX METALLOPROTEINASE-9 IN LUNG TISSUE OF PATIENTS WITH SEVERE ACUTE RESPIRATORY SYNDROME

Expression of matrix metalloproteinnse-2,9 in cholesteatoma from different positions

Clinical Significance of the Expression of Osteopontin and MMP-9 in Breast Cancer

Role of Matrix Metalloproteinases (mmps) in Tumor Invasion and Metastasis: Serial Studies on MMPs and TIMPs

Expression of MMP-9 Mrna in Human Hepatocellular Carcinoma

Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair

Clinical Significance of the Serum Matrix Metalloproteinase-9 (MMP-9) Expressions in Several Kinds of Gastric Diseases